This inventor holds 2 USPTO granted patents. Top assignees: Korea Research Institute of Chemical Technology, Gwangju Institute of Science and Technology, National Marine Biodiversity Institute of Korea. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022-2026
Title: The Innovations of Dong Ho Woo
Introduction
Dong Ho Woo is a notable inventor based in Chungcheongnam-do, South Korea. He has made significant contributions to the field of medical technology and chemical research. With a total of 2 patents, his work focuses on innovative solutions for health-related issues.
Latest Patents
Dong Ho Woo's latest patents include a composition for the prevention, amelioration, or treatment of urination-related diseases comprising cephalotocin. Additionally, he has developed a stereotactic device for primate brains. This device indicates a brain coordinate reference point of a primate using a simulator, providing an initial setting to a zero point corresponding to the brain coordinate reference point. This innovation allows for accurate targeting procedures on the brain without the need for expensive equipment, such as magnetic resonance imaging (MRI) scanners.
Career Highlights
Throughout his career, Dong Ho Woo has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and the Gwangju Institute of Science and Technology. His experience in these organizations has contributed to his expertise in developing groundbreaking technologies.
Collaborations
Some of his notable coworkers include Ji Young Park and Dong Hak Byun. Their collaborative efforts have further advanced the research and development of innovative solutions in their respective fields.
Conclusion
Dong Ho Woo's contributions to innovation in medical technology and chemical research highlight his role as a significant inventor. His patents reflect a commitment to improving health outcomes through advanced technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile